 HIGH POINT, N.C., Jan. 06, 2021 GLOBE NEWSWIRE -- vTv Therapeutics Inc. Nasdaq: VTVT a clinical-stage biopharmaceutical company focused on the development of orally administered treatments for type 1 diabetes and inflammatory diseases, today announced that it is participating in the LifeSci Partners 10th Annual Healthcare Corporate Access Event held virtually from January 11-14 2021. 